You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intratumoral injections

Showing 1 - 25 of 4,207
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Nonsmall Cell, Lung Cancer, Lung Cancer, Small Cell Trial in United States (NanoPac (sterile nanoparticulate

Active, not recruiting
  • Lung Cancer, Nonsmall Cell
  • +3 more
  • NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
  • Gainesville, Florida
  • +3 more
Jan 9, 2023

Melanoma Trial in Houston (LL37, Photographs)

Completed
Has Results
  • Melanoma
  • LL37
  • Photographs
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 7, 2021

Breast Cancer Female, Early-stage Breast Cancer Trial in Jette (Trimix, Placebo)

Recruiting
  • Breast Cancer Female
  • Early-stage Breast Cancer
  • Jette, Brussel, Belgium
    UZ Brussel
May 18, 2022

Triple Negative Breast Cancer, HER2-negative Breast Cancer Trial in Tampa (HER2 - primed Dendritic cells, HER3 - primed

Recruiting
  • Triple Negative Breast Cancer
  • HER2-negative Breast Cancer
  • HER2 - primed Dendritic cells
  • HER3 - primed Dendritic cells
  • Tampa, Florida
    Moffitt Cancer Center
Jan 10, 2023

Hepatocellular Carcinoma, Liver Cancer, Liver Tumors Trial in Xi'an (ET1402L1-ARTEMIS™ T cells -IV, ET1402L1-ARTEMIS™ T cells

Completed
  • Hepatocellular Carcinoma
  • +3 more
  • ET1402L1-ARTEMIS™ T cells -IV
  • +2 more
  • Xi'an, China
    The First Affiliated Hospital of Xi'an Jiaotong University
Mar 26, 2021

Advanced Solid Tumor Trial in Boston (VAX014)

Not yet recruiting
  • Advanced Solid Tumor
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 2, 2023

Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

Not yet recruiting
  • Squamous Cell Carcinoma of the Skin
  • +2 more
  • Marlborough, Massachusetts
    Phio Pharmaceuticals Corp.
Aug 25, 2023

Solid Tumors, Mycosis Fungoides, Melanoma Trial in United States (TTI-621 Monotherapy, TTI-621 + PD-1/PD-L1 Inhibitor, TTI-621 +

Terminated
  • Solid Tumors
  • +7 more
  • TTI-621 Monotherapy
  • +4 more
  • Duarte, California
  • +6 more
May 13, 2020

Metastatic Melanoma, Head Neck Cancer Trial in Worldwide (SD-101(1), Pembrolizumab, SD-101(2))

Terminated
Has Results
  • Metastatic Melanoma
  • Head Neck Cancer
  • Birmingham, Alabama
  • +46 more
Jul 12, 2021

B-cell Lymphoma Trial in United States (SD-101, Radiation therapy)

Terminated
Has Results
  • B-cell Lymphoma
  • Stanford, California
  • +4 more
Aug 20, 2020

Advanced Solid Tumor Trial (SGN1)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jan 30, 2023

Advanced Melanoma Trial in New York, Houston (LTX-315 in combination with pembrolizumab)

Recruiting
  • Advanced Melanoma
  • LTX-315 in combination with pembrolizumab
  • New York, New York
  • +7 more
Jan 23, 2023

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML

Recruiting
  • Non Small Cell Lung Cancer
  • Solid Tumor
  • Jette, Brussels, Belgium
  • +1 more
Sep 9, 2022

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023

Pancreatic Cancer Trial in Houston (genetic, drug, biological)

Recruiting
  • Pancreatic Cancer
  • delolimogene mupadenorepvec
  • +3 more
  • Houston, Texas
  • +1 more
Sep 16, 2022

Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)

Not yet recruiting
  • Advanced Solid Tumors
  • Recombinant human IL-21 oncolytic vaccinia virus injection
  • Hangzhou, Zhejiang, China
  • +1 more
Jun 21, 2023

Pancreas Cancer Trial in Nijmegen (QuiremSpheres®)

Recruiting
  • Pancreas Cancer
  • QuiremSpheres®
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Centre
Jan 2, 2022

Breast Tumors, Tumor Metastasis Trial in Boston, Canton (CodaLytic)

Not yet recruiting
  • Breast Neoplasms
  • Neoplasm Metastasis
  • CodaLytic
  • Boston, Massachusetts
  • +1 more
Oct 28, 2022

Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, Ovarian Cancer Trial in United States (mRNA-2416, Durvalumab)

Terminated
  • Relapsed/Refractory Solid Tumor Malignancies or Lymphoma
  • Ovarian Cancer
  • mRNA-2416
  • Durvalumab
  • Aurora, Colorado
  • +8 more
Jul 7, 2022

Advanced Malignant Solid Tumor, Extracranial Solid Tumor, Metastatic Malignant Solid Tumor Trial in Palo Alto (Anti-OX40

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Anti-OX40 Antibody BMS 986178
  • TLR9 Agonist SD-101
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jun 13, 2022

Advanced Cancer Trial in Villejuif (Ipilimumab, Nivolumab, Tilsotolimod)

Active, not recruiting
  • Advanced Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 21, 2021

Colorectal Cancer, Gastroesophageal Cancer, Ovarian Cancer Trial (IVX037)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • IVX037
  • (no location specified)
Jun 21, 2022

Solid Tumor Trial in United States (drug, combination product, biological)

Recruiting
  • Solid Tumor
  • Pembrolizumab
  • +2 more
  • Sacramento, California
  • +6 more
Jan 3, 2023

Carcinoma, Basal Cell, Carcinoma, Cutaneous Squamous Cell Trial in Tübingen, Warsaw, Saint Gallen (L19IL2 +L19TNF)

Recruiting
  • Carcinoma, Basal Cell
  • Carcinoma, Cutaneous Squamous Cell
  • L19IL2 +L19TNF
  • Tübingen, Germany
  • +2 more
Apr 19, 2022